IP Verse

Biomarkers For Risk Prediction Of Mortality - EP3213085

The patent EP3213085 was granted to F Hoffmann LA Roche on Sep 28, 2022. The application was originally filed on Oct 28, 2015 under application number EP15790874A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP3213085

F HOFFMANN LA ROCHE
Application Number
EP15790874A
Filing Date
Oct 28, 2015
Status
Patent Maintained As Amended
Aug 26, 2022
Grant Date
Sep 28, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

AMMELBURGSep 12, 2019FISH & RICHARDSON PCADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTWO2012025355
OPPOSITIONUS2007248981
OPPOSITIONWO2012025355

Non-Patent Literature (NPL) Citations (27) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- BRUMBACK L.C. et al., "Body size adjustments for left ventricular mass by cardiovascular magnetic resonance and their impact on left ventricular hypertrophy classification", The International Journal of Cardiac Imaging, (20100400), vol. 26, no. 4, pages 459 - 468, XP019787656-
OPPOSITION- MUREDDU G.F. et al., "Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy", European journal of heart failure, (20120000), vol. 14, no. 7, pages 718 - 729-
OPPOSITION- SATYAN S. et al., "Relationships of N-Terminal Pro-B-Natriuretic Peptide and Cardiac Troponin T to Left Ventricular Mass and Function and Mortality in Asymptomatic Hemodialysis Patients", AMERICAN JOURNAL OF KIDNEY DISEASES, (20071200), vol. 50, no. 6, pages 1009 - 1019-
OPPOSITION- SCHUSSHEIM A.E. et al., "Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension", AMERICAN JOURNAL OF CARDIOLOGY, (19981100), vol. 82, no. 9, pages 1056 - 1059-
OPPOSITION- SWAMY R.S. et al., "Echocardiographic Quantification of Left Ventricular Mass: Prognostic Implications", Curr. Cardiol. Rep., (20100320), vol. 12, no. 3, pages 277 - 282, XP055189306
OPPOSITION- MOTIWALA S.R. et al., "Measurement of Novel Biomarkers to Predict Chronic Heart Failure Outcomes and Left Ventricular Remodeling", J. Cardiovasc. Trans. Res., (20140000), vol. 7, pages 250 - 261, XP055143686
OPPOSITION- DE LEMOS J.A. et al., "Screening the population for left ventricular hypertrophy and left ventricular systolic dysfunction using natriuretic peptides: Results from the Dallas Heart Study", American Heart Journal, (20090400), vol. 157, no. 4, pages 746 - 753e2, XP026055158
OPPOSITION- GANDHI P.U. et al., "Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?", AMERICAN JOURNAL OF CARDIOLOGY, (20140827), vol. 114, pages 1543 - 1549, XP029082087
OPPOSITION- WANG Y.C. et al., "Soluble ST2 as a Biomarker for Detecting Stable Heart Failure With a Normal Ejection Fraction in Hypertensive Patients", Journal of Cardiac Failure, (20130300), vol. 19, no. 3, pages 163 - 168, XP055647531
OPPOSITION- NEELAND I.J. et al., "Biomarkers of Chronic Cardiac Injury and Hemodynamic Stress Identify a Malignant Phenotype of Left Ventricular Hypertrophy in the General Population", Journal of the American College of Cardiology, (20130102), vol. 61, no. 2, pages 187 - 195, XP055174223
OPPOSITION- ANGHELOIU G.O. et al., "Etiology of troponin I elevation in patients with congestive heart failure and low clinical suspicion of myocardial infarction", Resuscitation, (20041100), vol. 63, no. 2, pages 195 - 201, XP004628228
OPPOSITION- ISHII J. et al., "Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure", AMERICAN JOURNAL OF CARDIOLOGY, (20020315), vol. 89, no. 6, pages 691 - 695, XP002377628
OPPOSITION- SCHUSSHEIM A.E. et al., "Midwall fractional shortening is an independent predictor of left ventricular diastolic dysfunction in asymptomatic patients with systemic hypertension", AMERICAN JOURNAL OF CARDIOLOGY, (19981100), vol. 82, no. 9, pages 1056 - 1059, XP055647555
OPPOSITION- GINSBERG E. et al., "SOLUBLE ST2 PREDICTS INCIDENT HEART FAILURE AND CARDIOVASCULAR DEATH IN OLDER ADULTS", JACC, (20140401), vol. 63, no. 12, page A768, XP028600150
OPPOSITION- SCHIRMER H. et al., "Prevalence of left ventricular hypertrophy in a general population; The Tromsø Study", European Heart Journal, (19990000), vol. 20, pages 429 - 438, XP055647569
OPPOSITION- GOICOECHEA M. et al., "Clinical significance of cardiac troponin T levels in chronic kidney disease patients: predictive value for cardiovascular risk", AMERICAN JOURNAL OF KIDNEY DISEASES, (20040500), vol. 43, no. 5, pages 846 - 853, XP028834705
OPPOSITION- SATYAN S. et al., "Relationships of N-Terminal Pro-B-Natriuretic Peptide and Cardiac Troponin T to Left Ventricular Mass and Function and Mortality in Asymptomatic Hemodialysis Patients", AMERICAN JOURNAL OF KIDNEY DISEASES, (20071200), vol. 50, no. 6, pages 1009 - 1019, XP055647487
OPPOSITION- MCMURRAY J.J.V. et al., "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC", European Heart Journal, (20120519), vol. 33, no. 14, pages 1787 - 1847, XP055140708
OPPOSITION- MUREDDU G.F. et al., "Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy", European journal of heart failure, (20120000), vol. 14, no. 7, pages 718 - 729, XP008159821
OPPOSITION- CUSPIDI C. et al., "PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSION: AN UP-DATED ANALYSIS OF ECHOCARDIOGRAPHIC STUDIES", Journal of Human Hypertension, (20120000), vol. 26, pages 343 - 349, XP055647563
OPPOSITION- SHAH R.V. et al., "Serum Levels of the Interleukin-1 Receptor Family Member ST2, Cardiac Structure and Function, and Long-Term Mortality in Patients With Acute Dyspnea", Circulation Heart Failure, (2009), vol. 2, no. 2, pages 311 - 319, XP055647505
OPPOSITION- KY B. et al., "High-Sensitivity ST2 for Prediction of Adverse Outcomes in Chronic Heart Failure", Circulation Heart Failure, (20110300), vol. 4, no. 2, pages 180 - 187, XP055140798
OPPOSITION- DIEZ J. & FROHLICH E.D. et al., "A Translational Approach to Hypertensive Heart Disease", Hypertension, (20100100), vol. 55, no. 1, pages 1 - 8, XP055647536
OPPOSITION- SANADA S. et al., "IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system", JOURNAL OF CLINICAL INVESTIGATION, (20070600), vol. 117, no. 2, pages 1538 - 1549, XP008152558
OPPOSITION- MILLER W.L. et al., "Only Large Reductions in Concentrations of Natriuretic Peptides (BNP and NT-proBNP) Are Associated with Improved Outcome in Ambulatory Patients with Chronic Heart Failure", Clin. Chem., (20090101), vol. 55, no. 1, pages 78 - 84, XP055237474
OPPOSITION- SCIALLA J.J. et al., "Fibroblast Growth Factor-23 and Cardiovascular Events in CKD", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, (20140200), vol. 25, no. 2, pages 349 - 360, XP055647534
OPPOSITION- IQBAL N. et al., "Cardiac biomarkers: new tools for heart failure management", Cardiovasc. Diagn. Ther., (20120300), vol. 2, no. 2, pages 147 - 164, XP055570155

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents